Concepedia

Padhma Radhakrishnan

PR

Statistics

Publications

6

Citations

474

H-Index

6

Active since

2002

Affiliations

Mitra Biotech (India)(Current)

University of Massachusetts Chan Medical School

Kidwai Memorial Institute of Oncology

Padhma Radhakrishnan is an author at Mitra Biotech (India) specializing in medicine, oncology, and cancer cell signaling.

Publications per year

2002–2020

6

Publications

6

Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity

Biswanath Majumder, Ulaganathan Baraneedharan, Saravanan Thiyagarajan et al. · Nature Communications · 2015 · 310 citations · Full text

, , +17

Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer

Niraj Babu, Sneha M. Pinto, Manjusha Biswas et al. · Gastric Cancer · 2020 · 56 citations · Full text

, , +16

Point mutants of EHEC intimin that diminish Tir recognition and actin pedestal formation highlight a putative Tir binding pocket

Hui Liu, Padhma Radhakrishnan, Loranne Magoun et al. · Molecular Microbiology · 2002 · 35 citations · Full text

, , +16

Enhanced Actin Pedestal Formation by Enterohemorrhagic Escherichia coli O157:H7 Adapted to the Mammalian Host

Michael J. Brady, Padhma Radhakrishnan, Hui Liu et al. · Frontiers in Microbiology · 2011 · 28 citations · Full text

, , +17

Rationally co-targeting divergent pathways in KRAS wild-type colorectal cancers by CANscript technology reveals tumor dependence on Notch and Erbb2

Nilesh Brijwani, Misti Jain, Muthu Dhandapani et al. · Scientific Reports · 2017 · 23 citations · Full text

, , +17

1–5 of 6